Dr. Turnerstone is a visionary leader with an extensive background in software engineering. He has launched several companies in Asia by leveraging his technical expertise to integrate cutting-edge AI/ML technologies into pharmaceutical research and development processes as well as into medical devices. Dr. Turnerstone holds a Ph.D. in Computer Science with focus on AI and machine learning from University of Washington.

Mr. Clark background combines strong pharmaceutical industry and AI/ML applications experience. For more than 15 years, he has successfully led cross-functional teams and has applied strategic planning while managing large scale projects.

Dr. Scott is an experienced software engineer and system architect, with track record in executive roles. His educational background focuses on research and practical applications in machine learning and data analytics, in particular, developing small molecule drug discovery algorithms. Dr. Scott holds a Ph.D. in Computer Science from Georgia Institute of Technology

Dr. Huang has extensive experience in clinical development and integration of AI into drug development and clinical research. With a proven track record of leading clinical strategy and operations, he focuses on leveraging AI technologies to enhance patient outcomes and accelerate the drug discovery process.

Mr. Bennet has over 25 years of experience in the pharmaceutical industry. His proven expertise in financial planning and analysis, along with a strong track record of improving profitability and operational efficiency, are the drivers to support financial operation and sustainable growth.

Mr. Sharma leads the development and application of advanced analytics and machine learning models to extract actionable insights from large datasets, and inform drug discovery and development processes. In addition, collaborates with clinical institutions to initiate strategic partnerships and leads the seamless integration and implementation Alto Meds platform in their operations.

Dr. Adams has extensive experience in the pharmaceutical and biotechnology industries, combining deep regulatory expertise with a strong background in AI applications. He has a proven track record of successfully navigating complex regulatory environments, both FDA and EMA, to facilitate the approval of numerous cutting-edge therapies. His expertise in leveraging AI and data analytics to enhance regulatory decision-making processes is critical to streamline submission strategies, and improve compliance monitoring. Dr. Adams holds a Ph.D. in Pharmaceutical Sciences from University of California San Francisco (UCSF)

Ms. Liu has over 10 years of pharmaceutical industry experience in building and leading high-performing sales teams, fostering strong relationships with healthcare professionals, and navigating complex regulatory environments. She is firmly committed to driving organizational success through an innovative and customer-centered approach. Michelle holds an MBA from University of Pennsylvania-Wharton School, focusing on Marketing and Healthcare Management.

Ms. Smith is responsible for developing the people strategy aligned to the mission and vision of Alto Meds. She leads HR functions, providing key insights and expertise in building and sustaining a fast growing team and culture.